Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Approximately 9% of men and 18% of women suffer from migraine headaches. Almost all migraine sufferers report light sensitivity during a headache. Some people with migraine report that light can trigger their migraines and some people with migraine are light sensitive all of the time. The investigators have recently determined that certain colors of light are more likely to trigger migraines than other colors. In this study the investigators want to know if people who wear glasses that block these colors of light will have fewer migraine headaches.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Therapeutic Lens Coating | Experimental | Subjects will wear a therapeutic lens coating for 2 weeks |
|
| Sham Lens Coating | Sham Comparator | Subjects will wear a sham lens coating for 2 weeks |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Therapeutic Lens Coating | Other | Subjects will wear a therapeutic lens coating for 2 weeks. |
|
| Measure | Description | Time Frame |
|---|---|---|
| HIT-6 | Primary outcome measure is improvement in HIT-6 while wearing therapeutic lenses compared to baseline. The HIT-6 is the Headache Impact Test, a trademarked and copyrighted test (2001 QualityMetric, Inc. and GlaxoSmithKline Group of Companies) | 10 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Headache frequency and severity | Secondary outcome is reduction in headache frequency and severity as assessed by headache diaries. | 10 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Photophobia | Tertiary outcome is reduction in photophobia as assessed by a photophobia questionnaire. | 10 weeks |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bradley J Katz, MD | University of Utah | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| John A Moran Eye Center; University of Utah Hospitals and Clinics | Salt Lake City | Utah | 84132 | United States |
Not provided
| ID | Term |
|---|---|
| D008881 | Migraine Disorders |
| D020795 | Photophobia |
| D020325 | Migraine with Aura |
| D020326 | Migraine without Aura |
| D020773 | Headache Disorders |
| ID | Term |
|---|---|
| D051270 | Headache Disorders, Primary |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Sham Lens Coating | Other | Each subject will wear a sham lens coating for 2 weeks. |
|
| D014786 | Vision Disorders |
| D012678 | Sensation Disorders |
| D009461 | Neurologic Manifestations |
| D005128 | Eye Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |